CRISPR-Based Therapeutic Approaches in Lung Cancer

Résumé fourni par la source

This research paper explores the potential of CRISPR-based therapeutic approaches in the diagnosis, treatment, and management of lung cancer. It examines how CRISPR-Cas genome-editing technologies can be used to identify and modify cancer-associated genes, investigate molecular mechanisms of tumor development, and develop targeted therapeutic strategies. The study highlights the potential applications of CRISPR in precision oncology, including gene correction, cancer-cell targeting, drug resistance research, and personalized treatment. It also discusses current challenges and limitations, including off-target effects, delivery systems, tumor heterogeneity, safety concerns, and ethical considerations, while emphasizing the future potential of CRISPR technology in improving lung cancer therapy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.